Roche’s Bet On Next-Gen Sequencing Poses New Challenge For Illumina’s Market Dominance
With Sequencing By Expansion Technology A Year Away From Commercial Launch, Competition Takes Note As Of Now
Roche Diagnostics CEO Matthew Sause tells Medtech Insight about how the technology addresses the pricing challenges for mid- and low-throughput customers.
